Navigation Links
Scientific poster abstracts from the 24th annual meeting of the American Academy of Pain Medicine
Date:2/14/2008

ORLANDO Pain medicine investigators will present preliminary research findings on Thursday, February 14, 2008, at poster sessions held during the 24th annual meeting of the American Academy of Pain Medicine at the Gaylord Palms, Orlando, February 12-16, 2008.

All abstract titles are listed in this document. The introduction, conclusion, investigator listing, and funding source are included for eight abstracts identified as being of interest to the media.

100
Smoking and Neuropathic Pain

Introduction: This study aims to determine the percentage of community subjects with chronic neuropathic pain that smoke. (205 subjects)

Conclusions: Smoking was twice as common (62% versus 33%) in subjects that were diagnosed by clinical assessment as having neuropathic versus nociceptive pain. Similar differences were not found among those positive and negative on screening assessment for neuropathic pain. The possible physiological relationship between smoking and development of chronic neuropathic pain deserves further evaluation.

Investigators: Todd G. Call, MD Mayo, Toby N. Weingarten, MD, James C. Watson, MD, W. Michael Hooten, MD, Peter C. Wollan, PhD Mayo, Lee J. Melton, MD, Barbara P. Yawn, MD, Mayo Clinic College of Medicine, Rochester, MN

Editors note: Funding was provided by AstraZeneca and NIH grant AR30852.


102
What Are the Variables That Are Associated with the Patients Wish to Sue His Physician in Patients with Acute and Chronic Pain?

Objectives: Although there is limited research on patient attributes that may be related to reasons for launching a malpractice suit, no such research has been performed in patients with acute (APPS) or chronic (CPPS) pain. The objective of this study was then to develop some statistical models that would describe such patients attributes.

Conclusions: CPPS are at greater risk than patients without pain and APPS for harboring
'/>"/>

Contact: Amy Jenkins
amy@jenkinspr.com
312-836-0613
American Academy of Pain Medicine
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
2. Thomson Scientific Predicts Nobel Laureates
3. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
4. Thomson Scientific Announces BONDplus for Biological Researchers
5. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
6. International Society of Hair Restoration Surgery Hosts 15th Annual Scientific Meeting in Las Vegas, September 26-30, 2007
7. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
8. Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR)
9. Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines, Innovation and New Research
10. Milestone Scientific to Exhibit the STA(TM) System at the American Dental Associations 148th Annual Session in San Francisco
11. Delta Dental Plans Association Forms National Scientific Advisory Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...wed Banzel proved effective against Lennox-Gastaut... News) -- A new drug called Banzel (rufinamide) ha... severe form of epilepsy called Lennox-Gastaut syn...nced Friday. , The approval was based on result...ients ages 4 to 30. Compared to patients who took ...
(Date:11/21/2008)..., W.Va., Nov. 21 New re...whether a smokeless, spitless tobacco product aime...ers have found that RJ Reynolds, Camel Snus - tout...on - contains surprisingly high levels of nicotine...an most other snuff products," said Bruce Adkins o...
(Date:11/21/2008)...S.C., Nov. 21 U.S. News... Quality Assurance (NCQA) ranked BlueChoice(R) Hea...ica,s Best Health Plans(TM), published in U.S. New... The respected annual ranking ranks the nation,s b... satisfaction and NCQA accreditation scores. NCQA ...
(Date:11/21/2008)...N.J., Nov. 21 Barr Pharm...at its shareholders overwhelmingly approved the pr...ion of Barr by Teva Pharmaceuticals Industries Ltd...onstrated the overwhelming support of the transact...y, Barr,s Chairman and CEO. "We are pleased with t...
Breaking Medicine News(10 mins):Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4
...IV infected individuals, India plans to ask one yo...country to // teach others about safe sex and HIV,...rs, or agricultural laborers or just be hanging ar...ujatha Rao, director general of India's National A...
... Ltd Tuesday launched its branded inhalation capsu...que combination of long acting Beta2-agonist Formo...luticasone, the inhalation capsule Avessa is avail...0 mcg, Avessa 500 mcg, depending on the severity o...
...orld Health Organization has suggested that doctor...s may work against SARS// in the event of the retu...as conducted during and after the 2003 outbreak th...t find much evidence of any treatments employed th...
...ics and the particular bacteria causing some patie... Wake Forest University Baptist Medical Center has...y target the germs. “We matched the best antibioti...teristics and the particular bugs that we have in ...
Other Medicine News:Health News:Treatment of SARS Still a Mystery 2Health News:By Targeting Specific Germs, Hospital Hopes to Improve Pneumonia Treatment 2
(Date:11/19/2008)...v. 19 Posit Science Corporation,r...ociety for Neuroscience,Annual Conference in Wash...aining may benefit Baby Boomers. The computerized...) uses adaptive exercises that target auditory and... drive generalized,improvements in cognition by i...
(Date:11/19/2008)... did not achieve statistical significance , ,...- Pharmos Corporation (Nasdaq: PARS ) today anno...its topical NanoEmulsion (NE) drug delivery techno... , , The multi-center, randomized, double-b...ety and efficacy of the Company,s 3% Diclofenac Di...
(Date:11/19/2008)...., Nov. 19 Biotech scientists incr...icology research to better understand the effects ...tems, reports Genetic Engineering & Biotechno... in figuring out a new compound,s mechanism of act...ogy technique, according to the November 15 issue ...
(Date:11/19/2008)...ion Payment from Roche- , , MONTVALE, N.J.,...uticals Corp. (Nasdaq: MEMY ) today announced th...se 2 trial of R3487/MEM 3454, its lead alpha-7 nic...ssociated with schizophrenia (CIAS). The Company ...triggering a $5.0 million payment from its partner...
Breaking Medicine Technology:New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Depression during pregnancy can double risk of preterm delivery 5533 1Depression during pregnancy can double risk of preterm delivery 5533 2OrbitalPay LLC Implements Zecures Acquirer SAFE Solution to Stop Fraudulent E Commerce Merchants 5531 1OrbitalPay LLC Implements Zecures Acquirer SAFE Solution to Stop Fraudulent E Commerce Merchants 5531 2Unraveling the genetic picture of lung cancer 8496 1Unraveling the genetic picture of lung cancer 8496 2Biologists discover gene behind plant sex mystery 5529 1Biologists discover gene behind plant sex mystery 5529 2
...USINESS WIRE)--May 22, 2007 - Alequel(TM), an,indi... be an,effective treatment for moderate-to-severe ...ble-blind, placebo controlled Phase II,studies sug...od,clinical remissions and improved patients, qual...rs from Hebrew University-Hadassah,Medical Center,...
...ts importance of antiplatelet therapy compliance, ...PRNewswire-FirstCall/ -- Boston Scientific Corpora...ore than 7,000 patients from,its ARRIVE 1 and 2 re...e TAXUS(R) Express2(TM) paclitaxel- eluting corona...ctive of the analysis was,to identify baseline pre...
Other Medicine Technology:Enzo Biochem Individualized Oral Immune Regulation Therapy May Be,Effective Approach to Treating Crohn's Disease 2Enzo Biochem Individualized Oral Immune Regulation Therapy May Be,Effective Approach to Treating Crohn's Disease 3ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis,in Real-World Use of Drug-Eluting Stents 2ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis,in Real-World Use of Drug-Eluting Stents 3ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis,in Real-World Use of Drug-Eluting Stents 4
Eliminate preanalytical errors with automated QC module.
The TCM4 is able to detect patient changes and is portable.
Rapid exchange thrombectomy never handled like this before. ,Designed with tortuous anatomy in mind, the Spiroflex catheters unique spiral cut shaft, soft tip and hydrophilic coating provide out
Two separate sensors provide continuous measurement of tcpO2/tcpCO2 and SpO2.
Medicine Products: